- Investing Ideas
- /
- Swedish Healthcare High Growth Potential Companies
Swedish Healthcare High Growth Potential Companies
Results
31
3 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
31 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EQL New | SEK 66.40 | 4.4% | 105.6% | SEK 1.9b | SEK 65.00 | PE61.9x | E53.3% | n/a | ||
PAX | SEK 63.00 | -8.7% | 102.6% | SEK 1.2b | SEK 80.00 | PE45.6x | E60.8% | n/a | ||
CRAD B | SEK 27.75 | -4.8% | -30.9% | SEK 925.1m | SEK 49.00 | PE16.1x | E27.4% | n/a | ||
CEVI | SEK 214.50 | -7.9% | 22.2% | SEK 5.0b | SEK 270.00 | PE34.1x | E22.8% | 1.0% | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | ||
ORT B | SEK 11.00 | -4.3% | 23.9% | SEK 406.1m | SEK 20.00 | PS6.4x | E96.6% | n/a | ||
INTEG B | SEK 22.50 | 2.3% | -44.6% | SEK 446.1m | SEK 62.50 | PS4x | E87.2% | n/a | ||
RAY B | SEK 199.60 | 3.7% | 104.1% | SEK 6.7b | SEK 260.00 | PE45.3x | E26.2% | 0.4% | ||
NOSA | SEK 0.59 | -7.0% | -34.1% | SEK 126.1m | SEK 0.60 | PS8.4x | E87.0% | n/a | ||
ACARIX New | SEK 0.32 | -2.1% | 47.8% | SEK 339.3m | SEK 0.45 | PS60x | E110.4% | n/a | ||
IMP A SDB New | SEK 37.35 | -13.4% | 108.7% | SEK 11.0b | SEK 53.87 | PS455.1x | E42.9% | n/a | ||
XVIVO | SEK 446.00 | -4.5% | 71.2% | SEK 14.1b | SEK 538.17 | PE68.8x | E24.6% | n/a | ||
SECT B | SEK 284.80 | -2.6% | 133.6% | SEK 54.9b | SEK 240.00 | PE122.7x | E21.2% | 0.4% | ||
ARJO B | SEK 32.84 | -6.7% | -11.8% | SEK 9.0b | SEK 41.60 | PE17.7x | E24.5% | 2.7% | ||
MNTC | SEK 21.00 | -5.8% | -51.2% | SEK 539.5m | SEK 42.67 | PS1.9x | E116.7% | 0% | ||
KONT | SEK 2.66 | -1.5% | 9.5% | SEK 92.3m | SEK 5.40 | PE85.9x | E99.6% | n/a | ||
DIGN | SEK 1.20 | 10.1% | -45.5% | SEK 99.1m | SEK 5.70 | PS1.1x | E104.2% | n/a | ||
ATT | SEK 48.50 | -1.8% | 35.1% | SEK 7.5b | SEK 61.00 | PE18.8x | E24.3% | 2.1% | ||
GETI B | SEK 165.35 | -11.6% | -26.1% | SEK 45.4b | SEK 221.67 | PE26.6x | E21.2% | 2.7% | ||
BOUL | SEK 6.76 | -1.5% | -31.5% | SEK 264.8m | SEK 9.50 | PS0.5x | E103.4% | 0% | ||
SUS | SEK 146.10 | 5.5% | -11.7% | SEK 7.2b | SEK 192.17 | PE38.6x | E36.1% | n/a | ||
MCOV B | SEK 173.20 | -3.8% | 17.4% | SEK 26.0b | SEK 214.68 | PE113.7x | E40.9% | 0.8% | ||
MEDHLP | SEK 3.22 | 11.8% | 8.1% | SEK 92.5m | n/a | PS1.1x | E106.0% | n/a | ||
VIMIAN | SEK 42.85 | 2.3% | 68.0% | SEK 22.2b | SEK 48.44 | PE7545.9x | E89.8% | n/a |